Aug 15, 2022 / 12:30PM GMT
Operator
Greetings, and welcome to Medicenna Therapeutics Corp. First Quarter Fiscal 2023 Earnings Call. (Operator Instructions) As a reminder, this conference being recorded. It is now my pleasure to introduce your host, Daniel Ferry of Life Science. Thank you. You may proceed.
Daniel Ferry - LifeSci Advisors, LLC - MD & Relationship Manager
Thank you, operator, and thank you all for participating in today's conference call. This morning, Medicenna issued a press release providing financial results and corporate updates for the quarter ended June 30, 2022. If you have not yet seen the press release, it is available on the Investor page of Medicenna's website.
Before we begin, I would like to remind you that certain statements and information shared during this call constitute forward-looking information within the meaning of applicable securities laws. All statements other than statements of historical facts shared during this call and that relates to the future operations of the company and other statements that are not historical facts, including
Q1 2023 Medicenna Therapeutics Corp Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot